[The efficacy of nicardipine in treating arterial hypertension in elderly patients. A multicenter outpatient study].
In this open study, 210 patients from both sexes, age above 60 years and diagnosis of AHT, were included. All patients were treated, following the washing-out phase, with a calcium antagonist dihydropyridine: nicardipine, at a doses of 60 mg/day for 12 weeks. A significant reduction in SAP (from 168.97 to 152.25 mm Hg.) and DAP (from 98.17 to 87.63 mm Hg.) was observed, without modifications in the cardiac rate. In addition, a low incidence of adverse effects and a high biological tolerance of the drug has been demonstrated during the whole study.
Calvo Gómez
C
C
Departamento de Medicina, Hospital General de Galicia, Santiago de Compostela.
Lado Lado
F L
FL
Cinos Ramos
L
L
Pérez Leiros
P
P
Justo Firvida
E
E
D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D001794:Blood Pressure / Q000187:drug effects; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009529:Nicardipine / Q000009:adverse effects / Q000627:therapeutic use*; D013030:Spain
D009529:Nicardipine
Eficacia de la nicardipina en el tratamiento de la hipertensión arterial en pacientes ancianos. Estudio multicéntrico en régimen de ambulatorio.